igh rate of virologic suppression with darunavir / ritonavir lus optimized background therapy among highly ntiretroviral-experienced HIV-infected patients : results of a rospective cohort study in São Paulo , Brazil

@inproceedings{Vidala2013ighRO,
  title={igh rate of virologic suppression with darunavir / ritonavir lus optimized background therapy among highly ntiretroviral-experienced HIV-infected patients : results of a rospective cohort study in S{\~a}o Paulo , Brazil},
  author={os{\'e} Ernesto Vidala and Alice Tung Wan Songa and Maria Laura Matosa and Daniel Bartmanna and uilherme dos Anjosa and {\'E}rique Jos{\'e} Peixoto de Mirandaa and {\^A}ngela Carvalho Freitasa and irian de Freitas Dalbena and Claudinei Santanac and Alu{\'i}sio Cotrim Seguradoa and l{\'a}udia Cortese Barretod and Adri{\'a}n Vladimir Hern{\'a}ndezf},
  year={2013}
}
  • osé Ernesto Vidala, Alice Tung Wan Songa, +9 authors Adrián Vladimir Hernándezf
  • Published 2013
Objectives: To assess the virologic and immunological response of darunavir/ritonavir plus optimized background therapy in highly antiretroviral-experienced HIV-infected patients in